Marianne T Sweetser Selected Research

Marianne T Sweetser Research Topics

Disease

12	Amyloidosis 03/2024 - 01/2019
8	Polyneuropathies (Polyneuropathy) 03/2024 - 01/2018
5	Injection Site Reaction 07/2023 - 11/2020
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 01/2021
5	Pain (Aches) 11/2022 - 03/2006
5	Multiple Sclerosis 02/2017 - 09/2012
5	Relapsing-Remitting Multiple Sclerosis 02/2017 - 09/2012
4	Body Weight (Weight, Body) 10/2023 - 01/2018
3	Hyperoxaluria (Oxaluria) 01/2023 - 01/2021
3	Primary hyperoxaluria type 1 01/2023 - 01/2021
3	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2006 - 12/2005
2	Kidney Calculi (Kidney Stone) 03/2022 - 01/2021
2	Renal Insufficiency (Renal Failure) 03/2022 - 01/2021
2	Nephrocalcinosis 03/2022 - 01/2021
2	Nausea 01/2022 - 09/2012
2	Cardiomyopathies (Cardiomyopathy) 12/2020 - 01/2020
2	Transthyretin-Related Hereditary Amyloidosis 01/2019 - 01/2018
2	Flushing 09/2012 - 09/2012
2	Infections 03/2011 - 12/2005
1	Hepatic Porphyrias (Hepatic Porphyria) 12/2023
1	Spasm (Spasms) 10/2023
1	Arthralgia (Joint Pain) 10/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Hyperhomocysteinemia 09/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Iron Overload 01/2022
1	Fatigue 01/2022
1	Porphyrias (Porphyria) 11/2020
1	Acute Intermittent Porphyria (Porphyria, Acute) 11/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 09/2020
1	Orthostatic Intolerance 03/2020
1	Disease Progression 01/2019
1	Diarrhea 09/2012
1	Abdominal Pain (Pain, Abdominal) 09/2012
1	Pneumonia (Pneumonitis) 03/2011
1	Rheumatoid Arthritis 03/2011
1	Neoplasms (Cancer) 12/2005

Drug/Important Bio-Agent (IBA)

12	Prealbumin (Transthyretin)IBA 03/2024 - 01/2019
10	patisiranIBA 03/2024 - 01/2018
5	givosiranIBA 12/2023 - 11/2020
5	Dimethyl FumarateIBA 02/2017 - 09/2012
4	Hemin (Panhematin)FDA Link 11/2022 - 11/2020
4	Acute Hepatic PorphyriaIBA 09/2022 - 11/2020
3	lumasiranIBA 01/2023 - 01/2021
3	OxalatesIBA 01/2023 - 01/2021
3	Alefacept (Amevive)FDA Link 07/2006 - 12/2005
2	Heme (Haem)IBA 09/2022 - 01/2022
2	PorphobilinogenIBA 01/2022 - 11/2020
2	revusiranIBA 12/2020 - 01/2020
2	Transaminases (Aminotransferases)IBA 11/2020 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2020
2	Glatiramer Acetate (Copaxone)FDA Link 10/2013 - 09/2012
1	AngiotensinogenIBA 07/2023
1	Peptides (Polypeptides)IBA 07/2023
1	AngiotensinsIBA 07/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2022
1	HomocysteineIBA 09/2022
1	EnzymesIBA 01/2022
1	Aminolevulinic Acid (Levulan)FDA Link 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CreatinineIBA 11/2020
1	Methionine (L-Methionine)FDA Link 01/2020
1	Valine (L-Valine)FDA Link 01/2020
1	AntigensIBA 06/2014
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2014
1	Natalizumab (Tysabri)FDA Link 06/2014
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 06/2014
1	GoldIBA 10/2013
1	InterferonsIBA 09/2012
1	Tumor Necrosis Factor InhibitorsIBA 03/2011
1	Methotrexate (Mexate)FDA LinkGeneric 03/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011
1	Rituximab (Mabthera)FDA Link 03/2011
1	Adalimumab (Humira)FDA Link 03/2011
1	Etanercept (Enbrel)FDA Link 03/2011
1	AntibodiesIBA 12/2005

Therapy/Procedure

7	RNAi Therapeutics 03/2024 - 01/2018
3	Therapeutics 01/2019 - 12/2005
1	Intravenous Administration 11/2020
1	Phototherapy (Light Therapy) 07/2006